does semaglutide affect iron levels The effect of on intestinal absorption in patients with type 2 diabetes mellitus—A pilot study - Melis - 2025 - Diabetes, Obesity and Metabolism Anemia: A Lesser-Known Side Effect

Patient safety guidance should include: Education about expected appetite changes and strategies for maintaining adequate nutrition Monitoring for excessive weight loss or signs of malnutrition Assessment of mental health at follow-up visits Clear instructions to report severe or persistent nausea, vomiting, or neuropsychiatric symptoms Awareness that cognitive effects remain investigational and should not influence prescribing decisions Reporting severe persistent abdominal pain (pancreatitis), right upper quadrant pain/jaundice (gallbladder disease), severe abdominal distension with inability to pass gas or stool (possible ileus), persistent vomiting or signs of dehydration, and new/worsening vision changes (retinopathy) Understanding increased hypoglycemia risk when combined with insulin or sulfonylureas GLP-1 receptor agonists are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and should be used with caution in patients with severe gastrointestinal disease, including gastroparesis

Tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of MTC or with MEN2

While data on the exact effects of these medications on gut microbiota remains limited, adopting mindful eating habits such as chewing food slowly and supporting the production of digestive enzymes can aid in smooth digestion and help maintain microbial balance

Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors